Glucagon-like Peptide-1 receptor agonist prevented the Progression of Hepatocellular Carcinoma in a mouse model of nonalcoholic steatohepatitis
Real-world evidence from observational studies consistently shows that GLP-1 RA use is associated with reduced risk of hepatic decompensation even in patients with established cirrhosis, supporting cautious use in this population
GIP receptor agonism: Increases insulin sensitivity and contributes to body-weight control
With ginger and B6 to calm the stomach, peppermint oil and enzymes to support smooth digestion, and essential nutrients like D3, K2, and methylated B9 to replenish lost nutrients, this formula supports your bones, steady energy, and mental clarity while on GLP-1s
In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo